NPCE EBITDA Growth
Neuropace Inc · EBITDA Growth
NPCE EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported26.37%period ending
NPCE TTM EBITDA YoY % (-127.78% → 26.37%)
Year-over-year change
High-resolution chart · PNG
NPCE ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 26.368% | |
| 6.264% | |
| 23.2111% | |
| 15.9514% | |
| 19.906% | |
| 32.0894% | |
| 27.4153% | |
| 36.8167% | |
| 39.8491% | |
| 41.0033% | |
| 37.554% | |
| 24.7742% | |
| 5.0226% | |
| -17.5723% | |
| -28.8715% | |
| -65.4178% | |
| -95.5647% | |
| -93.6237% | |
| -127.7755% |